174 related articles for article (PubMed ID: 27010448)
1. Progress, challenges, and opportunities in Francisella vaccine development.
Elkins KL; Kurtz SL; De Pascalis R
Expert Rev Vaccines; 2016 Sep; 15(9):1183-96. PubMed ID: 27010448
[TBL] [Abstract][Full Text] [Related]
2. Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.
Griffin AJ; Crane DD; Wehrly TD; Bosio CM
Clin Vaccine Immunol; 2015 Jan; 22(1):119-28. PubMed ID: 25410207
[TBL] [Abstract][Full Text] [Related]
3. Adaptive Immunity to
Roberts LM; Powell DA; Frelinger JA
Front Cell Infect Microbiol; 2018; 8():115. PubMed ID: 29682484
[No Abstract] [Full Text] [Related]
4. Francisella tularensis Vaccines Elicit Concurrent Protective T- and B-Cell Immune Responses in BALB/cByJ Mice.
De Pascalis R; Mittereder L; Chou AY; Kennett NJ; Elkins KL
PLoS One; 2015; 10(5):e0126570. PubMed ID: 25973794
[TBL] [Abstract][Full Text] [Related]
5. Activities of Murine Peripheral Blood Lymphocytes Provide Immune Correlates That Predict Francisella tularensis Vaccine Efficacy.
De Pascalis R; Mittereder L; Kennett NJ; Elkins KL
Infect Immun; 2016 Apr; 84(4):1054-1061. PubMed ID: 26810039
[TBL] [Abstract][Full Text] [Related]
6. Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung.
Bar-On L; Cohen H; Elia U; Rotem S; Bercovich-Kinori A; Bar-Haim E; Chitlaru T; Cohen O
Vaccine; 2017 Dec; 35(50):7001-7009. PubMed ID: 29102170
[TBL] [Abstract][Full Text] [Related]
7. Vaccination strategies for Francisella tularensis.
Isherwood KE; Titball RW; Davies DH; Felgner PL; Morrow WJ
Adv Drug Deliv Rev; 2005 Jun; 57(9):1403-14. PubMed ID: 15919131
[TBL] [Abstract][Full Text] [Related]
8. Nature of protective immunity to Francisella tularensis.
Tärnvik A
Rev Infect Dis; 1989; 11(3):440-51. PubMed ID: 2665002
[TBL] [Abstract][Full Text] [Related]
9. Expansion and retention of pulmonary CD4
Roberts LM; Wehrly TD; Crane DD; Bosio CM
Vaccine; 2017 May; 35(19):2575-2581. PubMed ID: 28372827
[TBL] [Abstract][Full Text] [Related]
10. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A.
Wu TH; Hutt JA; Garrison KA; Berliba LS; Zhou Y; Lyons CR
Infect Immun; 2005 May; 73(5):2644-54. PubMed ID: 15845466
[TBL] [Abstract][Full Text] [Related]
11. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
[TBL] [Abstract][Full Text] [Related]
12. A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.
De Pascalis R; Hahn A; Brook HM; Ryden P; Donart N; Mittereder L; Frey B; Wu TH; Elkins KL
PLoS One; 2018; 13(5):e0198140. PubMed ID: 29799870
[TBL] [Abstract][Full Text] [Related]
13. Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria.
Ryden P; Twine S; Shen H; Harris G; Chen W; Sjostedt A; Conlan W
Mol Immunol; 2013 May; 54(1):58-67. PubMed ID: 23201853
[TBL] [Abstract][Full Text] [Related]
14. Development of functional and molecular correlates of vaccine-induced protection for a model intracellular pathogen, F. tularensis LVS.
De Pascalis R; Chou AY; Bosio CM; Huang CY; Follmann DA; Elkins KL
PLoS Pathog; 2012 Jan; 8(1):e1002494. PubMed ID: 22275868
[TBL] [Abstract][Full Text] [Related]
15. Virulence determinants and protective antigens of Francisella tularensis.
Sjöstedt A
Curr Opin Microbiol; 2003 Feb; 6(1):66-71. PubMed ID: 12615222
[TBL] [Abstract][Full Text] [Related]
16. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
Baron SD; Singh R; Metzger DW
Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
[TBL] [Abstract][Full Text] [Related]
17. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
KuoLee R; Harris G; Conlan JW; Chen W
Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
[TBL] [Abstract][Full Text] [Related]
18. Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis.
Shen H; Chen W; Conlan JW
Microb Pathog; 2004 Aug; 37(2):107-10. PubMed ID: 15312850
[TBL] [Abstract][Full Text] [Related]
19. Immune lymphocytes halt replication of Francisella tularensis LVS within the cytoplasm of infected macrophages.
Bradford MK; Elkins KL
Sci Rep; 2020 Jul; 10(1):12023. PubMed ID: 32694562
[TBL] [Abstract][Full Text] [Related]
20. Francisella tularensis vaccines.
Griffin KF; Oyston PC; Titball RW
FEMS Immunol Med Microbiol; 2007 Apr; 49(3):315-23. PubMed ID: 17316369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
